Tag: Biotechnology Research

Halda Therapeutics
United States

Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer

Brings proven leadership and successful track record to Halda as the company enters the next stage of growth as clinical-stage company NEW HAVEN, Conn. – Halda Therapeutics, a biotechnology company developing a novel class of cancer therapies called RIPTAC™ (Regulated Induced Proximity TArgeting Chimeras) therapeutics, today announced that it has appointed Christian Schade as President and Chief Executive Officer and a member of the Board of … Continue reading Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer

Impact Newswire
Prothena
Europe

Prothena Announces Leadership Team Updates

DUBLIN – Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that Chad Swanson, Ph.D., has been appointed Chief Development Officer and will assume leadership of clinical development and medical functions. Chad will join Prothena’s executive leadership team and will report to Gene Kinney, Ph.D., President and Chief Executive Officer. Hideki … Continue reading Prothena Announces Leadership Team Updates

Impact Newswire
Eurofins
Europe

Eurofins Sustainability Services Introduces EUDR Deforestation Impact Assessment

Pairing customer-centric support and tailored assessments to trace raw material origin in supply chains. NORTHAMPTON, United Kingdom – Eurofins Sustainability Services (Paris:ERF), a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include a deforestation impact assessment. The European Union’s Deforestation Regulation (EUDR) aims to prevent the import and sale of products linked to deforestation in the EU … Continue reading Eurofins Sustainability Services Introduces EUDR Deforestation Impact Assessment

Impact Newswire
ADOCIA
Europe

ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer

LYON, France–(BUSINESS WIRE)–Regulatory News: “We have had the time for a thorough transition with Mathieu, and I have come to appreciate his skills and strategic vision. Lastly, I would like to thank Gérard and Olivier for trusting me and for the intense and rewarding years we have spent together.” Post this Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on … Continue reading ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer

Impact Newswire
Accellix
United States

Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets

SAN JOSE, Calif. & JERUSALEM – Accellix, Inc., the leading sample to answer flow cytometry GMP platform company, is pleased to announce the appointment of Greg Hamilton as Chief Executive Officer and member of the Board effective September 23, 2024. He brings over 25 years of management experience in molecular diagnostics, life science tools, manufacturing and professional service industries as the company ramps growth in … Continue reading Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets

Impact Newswire
Prilenia
United States

Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer

Expanded leadership team positioned to advance the company’s development and commercialization plans NAARDEN, The Netherlands & WALTHAM, Mass. – Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of two key leaders to its management team – Mr. Rob Lauzen as Chief Financial … Continue reading Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer

Impact Newswire
Novotech
United States

Novotech Earns Great Place to Work® Certification in the United States

BOSTON – Novotech, a global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been certified as a Great Place to Work® in the United States. This award reflects Novotech’s commitment to fostering a flexible, inclusive, and innovative work environment where employees feel supported and empowered to contribute to the future of medical research. “Our employees are the heart of Novotech, … Continue reading Novotech Earns Great Place to Work® Certification in the United States

Impact Newswire
CorriXR Therapeutics
United States

CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors

OKLAHOMA CITY – CorriXR Therapeutics, Inc. (“CorriXR”), a biotherapeutics company developing unique genetic medicines that optimize the effectiveness of existing cancer treatments by knocking out genes responsible for resistance, today announced the appointment of Jill Castilla to its Board of Directors. Ms. Castilla brings visionary leadership as a nationally recognized innovator in finance and banking. “We are very pleased to welcome Jill to our Board … Continue reading CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors

Impact Newswire